FWFei Wang

Fei Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fei Wang has a total of 82 co-authors. Here are the top co-authors by number of shared publications:

  • Changqing Yang

    Department of Gastroenterology and Hepatology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China

    2 shared publications
  • Baoqin Xuan

    Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases, State Key Laboratory of Systems Medicine for Cancer, Hospital of Digestive Disease, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

    1 shared publication
  • Bei Li

    Division of Biliary Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China

    1 shared publication
  • Bin Yu

    State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Shanghai Key Laboratory for Cancer Systems Regulation and Clinical Translation, Shanghai Jiao Tong University, Shanghai, People’s Republic of China

    1 shared publication
  • Bingyuan Huang

    Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200001, China

    1 shared publication
  • Bo Tu

    Clinical Research Division Fred Hutchinson Cancer Research Center Seattle WA 98109 USA

    1 shared publication

Latest Publications

  • Fusobacterium nucleatum enhances enterotoxigenic Bacteroides fragilis-mediated neuron loss and intestinal motility dysfunction

    by Yue Zhang, Ying Zhao, Lu Zhang, Baoqin Xuan, Zhenyu Wang, Bin Yu, Weixun Li, Xiaowen Huang, Yilu Zhou, Lijun Ning, et al.

    Gut dysmotility is a common long-term effect of enterotoxigenic Bacteroides fragilis (ETBF) colonization but the underlying mechanisms are not clear. Here, using mouse colonization models, we found that ETBF-secreted B. fragilis toxin (BFT) causes loss of colonic myenteric neurons, which are crucial regulators of intestinal motility. BFT induced apoptosis in these neurons through the NOD1–RIPK2–CASP9–CASP3 pathway, leading to gut dysmotility that persisted even after the clearance of ETBF. Analyses of human inflammatory bowel disease and colorectal cancer patient cohorts showed a positive correlation between ETBF and Fusobacterium nucleatum abundance. In mice, F. nucleatum-derived 2-hydroxybutyric acid enhanced BFT production in ETBF by alleviating RprY-mediated suppression and aggravated neurotoxicity and dysmotility. This enteric neuron loss and dysmotility enhanced susceptibility to dextran sulfate sodium-induced colitis in mice. Therapeutically, a Bifidobacterium-based probiotic attenuated neuron toxicity and improved intestinal motility. Our findings reveal bacterial interactions regulating intestinal function and a potential clinical therapeutic approach to preventing outcomes of ETBF colonization.


  • Open Access

    RUNX1-mediated repression of miR-24 promotes hepatic stellate cell activation and liver fibrosis by targeting the ALK4/Smad3 signaling pathway

    by Zhijing Wang, Meiyi Song, Yingying Zhao, Jing Li, Lu Xia, Fei Wang, Changqing Yang

    Background: Epigenetic mechanisms, including microRNAs (miRNAs), are increasingly recognized as crucial regulators of organ fibrosis. In this study, we investigated the role of miR-24 in hepatic stellate cell (HSC) activation and liver fibrosis. Methods: miR-24 expression was analyzed in carbon tetrachloride (CCl 4 )-induced liver fibrosis and activated HSCs using quantitative real-time PCR (qRT-PCR). Gain- and loss-of-function experiments of miR-24 were performed in vitro . Western blotting, qRT-PCR, 5-ethynyl-2′-deoxyuridine (EdU) staining, flow cytometry, luciferase reporter assays, bioinformatics analysis, and chromatin immunoprecipitation PCR (ChIP-PCR) were performed to examine the molecular mechanisms of miR-24. Serum miR-24 levels were measured in patients with liver cirrhosis and further analyzed by subgroup. Results: We observed significant downregulation of miR-24 in CCl 4 -induced liver fibrosis and activated HSCs. Functional assays showed that miR-24 overexpression markedly inhibited HSC activation and migration, whereas miR-24 inhibition had the opposite effects. Mechanistically, ALK4 was identified as a direct target of miR-24: miR-24 bound the 3′UTR of ALK4 mRNA, thereby suppressing Smad3 phosphorylation and downstream fibrosis-associated signaling pathways. Furthermore, the transcription factor RUNX1 was induced during HSC activation, and it transcriptionally repressed miR-24 expression. Clinically, serum miR-24 levels were significantly lower in patients with liver cirrhosis than in healthy controls and were negatively correlated with Child–Pugh grade. Conclusion: Our findings suggest that the RUNX1/miR-24/ALK4 axis plays a crucial role in HSC activation and migration. miR-24 may serve as a biomarker for liver fibrosis screening, representing a potential therapeutic target for anti-fibrotic intervention.


  • Top Cited Papers
    Open Access

    Epigenetically controlled endothelial promyelocytic leukemia drives liver inflammation and fibrosis

    by Can Gan, Enjiang Lai, Yang Tai, Shuai Chen, Chong Zhao, Wenting Dai, Zhu Yang, Bei Li, Tian Lan, Yang Xiao, et al.

    Cellular and molecular heterogeneity in the liver has been increasingly recognized to drive liver fibrosis progression, but the particular events that occur initially in response to liver injury and trigger immune cell recruitment remain unclear. Here, we identify epigenetically aberrant liver sinusoidal endothelial cells (LSECs) as key players in this process. Mechanistically, the epigenetic readers like bromodomain-containing protein 4–dependent (BRD4-dependent) super enhancers (SEs) activate proinflammatory genes, including promyelocytic leukemia (PML). The PML protein, in turn, binds BRD4 and amplifies proinflammatory angiocrine signaling through phase separation–dependent SE activation via PML/BRD4 condensate formation. In mouse models, LSEC-specific depletion of the PML/BRD4 complex mitigates liver inflammation and fibrosis. Single-cell RNA-seq reveals that epigenetically aberrant LSECs exhibit a reprogrammed proinflammatory angiocrine landscape in mouse fibrotic livers. TIMP1 + LSECs promote the recruitment of CD63 + monocyte–derived macrophages (MoMFs) during liver fibrosis progression. Thereby, PML/BRD4 in LSECs governs inflammatory immune cell recruitment in liver fibrosis. Pharmacological BRD4 inhibition or epigenetic PML-SE repression alleviates liver inflammation and fibrosis. In conclusion, PML/BRD4-mediated SE activation via phase separation drives proinflammatory angiocrine signaling in LSECs, initiating the inflammatory cascade and subsequent immune cell recruitment during liver fibrosis.


  • Open Access

    Src Reduces Neutrophil Extracellular Traps Generation and Resolves Acute Organ Damage

    by Guotao Lu, Fei Han, Yaodong Wang, Chenchen Yuan, Qingtian Zhu, Tianqi Xia, Lin Chen, Xiaowu Dong, Yanbing Ding, Weiming Xiao, et al.

    Neutrophil extracellular traps (NETs) are key factors mediating acute inflammatory injury. However, the underlying mechanisms and potential therapeutic targets remain unclear. Previous results suggest Src may be involved in regulating the NETs formation. Here, Src is found activated in the NETs model in vitro, in the murine‐ and human‐derived neutrophils (acute pancreatitis and sepsis). Moreover, p‐Src expression correlates with the clinical prognosis of acute pancreatitis and sepsis patients. Meanwhile, the inhibition of Src activity (gene silencing or inhibitors) inhibits NETs formation in vitro. Mechanistically, Src directly activates RAF1 by regulating phosphorylation at the Ser 621 site and mediates the RAF/MEK/ERK pathway, thereby affecting the intracellular ROS production. Alternatively, Src activates the RAF/MEK/ERK pathway by mediating PKC phosphorylation. In vivo, neutrophil Src ‐ specific defect significantly reduces acute inflammatory response, organ damage, and the NETs formation in damaged tissue. Eventually, Src inhibitors are used and validated their pharmacological effects. These results identify Src as a key mediator in intracellular ROS production, NETs formation, and acute organ injury. Hence, Src inhibition may represent a promising therapeutic strategy for treating acute organ injury.


  • Myeloid MAS–driven macrophage efferocytosis promotes resolution in ischemia-stressed mouse and human livers

    by Shuai Chen, Bingyuan Huang, Shanshan Li, Zhijing Wang, Yizhong Chang, Huaming Huang, Chun Liu, Shuo Zhang, Manchang Jin, Haoyu Jia, et al.

    Liver ischemia-reperfusion injury (LIRI) is an inevitable detrimental event after liver transplantation. The MAS receptor plays a protective role in various diseases. However, the specific roles of MAS in myeloid cell innate immunity and the maintenance of hepatic tissue homeostasis remain unclear. Here, we showed that mice with systemic, Kupffer cell–specific, or myeloid cell–specific Mas1 deficiency were vulnerable to LIRI. Single-cell RNA sequencing, spatial transcriptomics, and intravital imaging revealed that myeloid deficiency of Mas1 resulted in impaired macrophage efferocytosis by down-regulating MER tyrosine kinase (MERTK), leading to the accumulation of aged neutrophils and exacerbation of inflammation and pathology. Mechanistic studies indicated that the MAS receptor regulated the Krüppel-like factor 4 (KLF4)/MERTK axis in macrophages via the protein kinase A (PKA)/cAMP response element–binding protein (CREB) signaling pathway. KLF4 directly bound to the promoter region of MERTK and transcriptionally promoted its expression in macrophages, leading to attenuation of the liver inflammatory response. Macrophage-specific knockout of KLF4 and MERTK in the mice also resulted in impaired macrophage efferocytosis with the accumulation of aged neutrophils. Macrophage-specific overexpression of KLF4 in vivo effectively reversed the phenotype exacerbated by myeloid Mas1 deficiency. In addition, we demonstrated that MAS + MERTK + macrophages actively migrated toward aged neutrophils in ischemia-stressed human livers, thereby promptly clearing aged neutrophils. In summary, this study documented the regulatory function of the MAS/KLF4/MERTK axis in macrophage efferocytosis via PKA/CREB signaling. This axis may thus serve as a therapeutic target and checkpoint regulator of homeostasis in response to LIRI.